SCHEMBL26328301

SCHEMBL26328301

Cc1ccc(NC(C)(C)C)cc1C#N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
CSNK1D P48730 1/20 0.39
CSNK1G2 P78368 1/20 0.39
SLC22A12 Q96S37 6/20 0.38
HTT P42858 1/20 0.35
ALDH1A1 P00352 4/20 0.34
BACE2 Q9Y5Z0 1/20 0.34
EGFR P00533 1/20 0.33
ABCG2 Q9UNQ0 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 2/20 0.32
ALOX15 P16050 2/20 0.32
CASP1 P29466 2/20 0.32
CASP7 P55210 2/20 0.32
HSD17B10 Q99714 2/20 0.32
USP2 O75604 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21966924 0.79 TSHR (0.45) TSHRCSNK1DCSNK1G2SLC22A12HTT
SCHEMBL27483267 0.78 HTT (0.46) TSHRSLC22A12HTTALDH1A1BACE2
SCHEMBL2136354 0.77 TSHR (0.43) TSHRCSNK1DCSNK1G2SLC22A12HTT
SCHEMBL12883425 0.76 POLB (0.45) HTTALDH1A1MAPTALOX15HSD17B10
SCHEMBL26546116 0.76 ABCG2 (0.48) TSHRCSNK1DCSNK1G2SLC22A12HTT
Hydrochloric Acid SCHEMBL2905515 0.76 TSHR (0.42) TSHRCSNK1DCSNK1G2SLC22A12HTT
SCHEMBL10986676 0.74 TSHR (0.41) TSHRCSNK1DCSNK1G2SLC22A12HTT
SCHEMBL3054694 0.74 SLC22A12 (0.55) SLC22A12
SCHEMBL25379565 0.73 NPSR1 (0.48) TSHRSLC22A12HTTALDH1A1BACE2
SCHEMBL29177229 0.73 ALDH1A1 (0.50) HTTALDH1A1NPC1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230279023-A1 N/O-Linked Degrons and Degronimers for Protein Degradation C4 THERAPEUTICS, INC. (US) 2023-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230279023-A1 N/O-Linked Degrons and Degronimers for Protein Degradation CRBN, CBL, STUB1 TSHR 1050/4885CSNK1D 1206/4885CSNK1G2 739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.